Viatris VTRS
NASDAQ VTRS
$16.50 -0.11 (-0.66%)
As of: Sep 9, 2026 · 3:59 PM EDT

Viatris (VTRS) Assets (2019 - 2026)

Viatris (VTRS) posted Assets of $35.0 billion for Q2 2026, down 4.86% on a QoQ basis from $36.8 billion in Q1 2026, and down 8.77% year-over-year from $38.4 billion in Q2 2025.

Analysis

Viatris (VTRS) Assets (2019 - 2026) Analysis & Trends

Viatris has reported Assets for 8 years, with the latest figure at $35.0 billion in Q2 2026.

  • On a quarterly basis, Assets fell 8.77% year-over-year to $35.0 billion in Q2 2026; TTM through Jun 2026 was $35.0 billion, a 8.77% decrease from a year earlier, with the FY2025 full-year figure at $37.2 billion, down 10.38% from the prior year.
  • Assets was $35.0 billion for Q2 2026 at Viatris, down from $36.8 billion in the prior quarter.
  • The five-year high for Assets was $53.5 billion in Q1 2022, with the low at $35.0 billion in Q2 2026.
  • Average Assets over 5 years is $44.5 billion, with a median of $46.3 billion recorded in 2024.
  • The sharpest annual moves came in 2023 and 2025: Assets increased 0.16% in 2023, then dropped 18.73% in 2025.
  • Over 5 years, Assets stood at $50.0 billion in 2022, then slipped by 4.67% to $47.7 billion in 2023, then slipped by 12.97% to $41.5 billion in 2024, then dropped by 10.38% to $37.2 billion in 2025, then decreased by 5.78% to $35.0 billion in 2026.
  • The last three Assets figures came in at $35.0 billion (Q2 2026), $36.8 billion (Q1 2026), and $37.2 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn 39.86 Bn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn 35.04 Bn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn 6.08 Bn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn 3.78 Bn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn 24.79 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn 1.59 Bn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn 1.49 Bn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn 1.74 Bn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn 75.75 Mn
10 RedHill Biopharma 178.35 Mn 178.35 Mn - 25.35 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 35.04 Bn
Mar 31, 2026 36.83 Bn
Dec 31, 2025 37.19 Bn
Sep 30, 2025 37.92 Bn
Jun 30, 2025 38.41 Bn
Mar 31, 2025 38.47 Bn
Dec 31, 2024 41.50 Bn
Sep 30, 2024 44.75 Bn
Jun 30, 2024 45.33 Bn
Mar 31, 2024 47.34 Bn
Dec 31, 2023 47.69 Bn
Sep 30, 2023 48.74 Bn
Jun 30, 2023 48.70 Bn
Mar 31, 2023 49.29 Bn
Dec 31, 2022 50.02 Bn
Sep 30, 2022 48.66 Bn
Jun 30, 2022 51.13 Bn
Mar 31, 2022 53.47 Bn
Dec 31, 2021 54.84 Bn
Sep 30, 2021 56.07 Bn